Mihir Shah's most recent trade in Jones Lang Lasalle Inc. was a trade of 6,183 Restricted Stock Units done . Disclosure was reported to the exchange on Feb. 15, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Jones Lang Lasalle Inc | Mihir Shah | CEO, JLL Technologies | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2026 | 6,183 | 0 | - | - | Restricted Stock Units | |
| Jones Lang Lasalle Inc | Mihir Shah | CEO, JLL Technologies | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2026 | 6,183 | 51,398 (0%) | 0% | 0 | Common Stock | |
| Jones Lang Lasalle Inc | Mihir Shah | CEO, JLL Technologies | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2026 | 3,724 | 47,187 (0%) | 0% | 0 | Common Stock | |
| Jones Lang Lasalle Inc | Mihir Shah | CEO, JLL Technologies | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2026 | 3,724 | 7,451 | - | - | Restricted Stock Units | |
| Jones Lang Lasalle Inc | Mihir Shah | CEO, JLL Technologies | Payment of exercise price or tax liability using portion of securities received from the company at price $ 289.15 per share. | 15 Feb 2026 | 3,290 | 48,108 (0%) | 0% | 289.2 | 951,304 | Common Stock |
| Jones Lang Lasalle Inc | Mihir Shah | CEO, JLL Technologies | Payment of exercise price or tax liability using portion of securities received from the company at price $ 289.15 per share. | 15 Feb 2026 | 1,972 | 45,215 (0%) | 0% | 289.2 | 570,204 | Common Stock |
| Jones Lang Lasalle Inc | Mihir Shah | CEO, JLL Technologies | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2025 | 5,563 | 5,563 | - | - | Restricted Stock Units | |
| Jones Lang Lasalle Inc | Mihir Shah | CEO, JLL Technologies | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2025 | 1,612 | 44,315 (0%) | 0% | 0 | Common Stock | |
| Jones Lang Lasalle Inc | Mihir Shah | CEO, JLL Technologies | Payment of exercise price or tax liability using portion of securities received from the company at price $ 245.90 per share. | 31 Mar 2025 | 852 | 43,463 (0%) | 0% | 245.9 | 209,507 | Common Stock |
| Jones Lang Lasalle Inc | Mihir Shah | CEO JLL Technologies | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 4,136 | 0 | - | - | Restricted Stock Units | |
| Jones Lang Lasalle Inc | Mihir Shah | CEO JLL Technologies | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 4,136 | 44,905 (0%) | 0% | 0 | Common Stock | |
| Jones Lang Lasalle Inc | Mihir Shah | CEO JLL Technologies | Payment of exercise price or tax liability using portion of securities received from the company at price $ 282.69 per share. | 15 Feb 2025 | 2,202 | 42,703 (0%) | 0% | 282.7 | 622,483 | Common Stock |
| Jones Lang Lasalle Inc | Shah Mihir | CEO JLL Technologies | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2024 | 11,175 | 11,175 | - | - | Restricted Stock Units | |
| Jones Lang Lasalle Inc | Mihir Shah | CEO JLL Technologies | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2024 | 7,450 | 7,450 | - | - | Restricted Stock Units | |
| Oncology Institute Inc | Mihir Shah | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 378,648 | 378,648 | - | - | Non-Qualified Stock Option (right to buy) | |
| Oncology Institute Inc | Mihir Shah | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 151,459 | 474,931 | - | 0 | Common Stock | |
| Jones Lang Lasalle Inc | Mihir Shah | Co-CEO JLL Technologies | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Apr 2024 | 7,945 | 7,945 | - | - | Restricted Stock Units | |
| Jones Lang Lasalle Inc | Mihir Shah | Co-CEO JLL Technologies | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2024 | 9,222 | 45,444 (0%) | 0% | 0 | Common Stock | |
| Jones Lang Lasalle Inc | Mihir Shah | Co-CEO JLL Technologies | Payment of exercise price or tax liability using portion of securities received from the company at price $ 195.09 per share. | 31 Mar 2024 | 4,675 | 40,769 (0%) | 0% | 195.1 | 912,046 | Common Stock |
| Jones Lang Lasalle Inc | Shah Mihir | Co-CEO JLL Technologies | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2024 | 4,634 | 0 | - | - | Restricted Stock Units | |
| Jones Lang Lasalle Inc | Mihir Shah | Co-CEO JLL Technologies | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2024 | 4,634 | 37,896 (0%) | 0% | 0 | Common Stock | |
| Jones Lang Lasalle Inc | Mihir Shah | Co-CEO JLL Technologies | Payment of exercise price or tax liability using portion of securities received from the company at price $ 192.73 per share. | 15 Feb 2024 | 1,674 | 36,222 (0%) | 0% | 192.7 | 322,630 | Common Stock |
| Oncology Institute Inc | Shah Mihir | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 1.27 per share. | 14 Dec 2023 | 99,435 | 327,557 | - | 1.3 | 126,282 | Common stock |
| Oncology Institute Inc | Mihir Shah | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 1.25 per share. | 14 Dec 2023 | 565 | 328,122 | - | 1.2 | 706 | Common stock |
| Oncology Institute Inc | Mihir Shah | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.43 per share. | 23 May 2023 | 2,573 | 224,341 | - | 0.4 | 1,101 | Common Stock |
| Oncology Institute Inc | Mihir Shah | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.43 per share. | 23 May 2023 | 869 | 223,472 | - | 0.4 | 372 | Common Stock |
| Jones Lang Lasalle Inc | Mihir Shah | Co-CEO JLL Technologies | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Apr 2023 | 6,183 | 6,183 | - | - | Restricted Stock Units | |
| Jones Lang Lasalle Inc | Mihir Shah | Co-CEO JLL Technologies | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 20,298 | 43,326 (0%) | 0% | 0 | Common Stock | |
| Jones Lang Lasalle Inc | Mihir Shah | Co-CEO JLL Technologies | Payment of exercise price or tax liability using portion of securities received from the company at price $ 141.22 per share. | 31 Mar 2023 | 10,064 | 33,262 (0%) | 0% | 141.2 | 1,421,238 | Common Stock |
| Oncology Institute Inc | Mihir Shah | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2023 | 440,477 | 440,477 | - | - | Non-Qualified Stock Option (right to buy) | |
| Oncology Institute Inc | Mihir Shah | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2023 | 176,191 | 226,914 | - | 0 | Common stock | |
| Jones Lang Lasalle Inc | Mihir Shah | Co-CEO JLL Technologies | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jan 2023 | 909 | 0 | - | - | Restricted Stock Units | |
| Jones Lang Lasalle Inc | Mihir Shah | Co-CEO JLL Technologies | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jan 2023 | 909 | 23,387 (0%) | 0% | 0 | Common Stock | |
| Jones Lang Lasalle Inc | Mihir Shah | Co-CEO JLL Technologies | Payment of exercise price or tax liability using portion of securities received from the company at price $ 177.16 per share. | 16 Jan 2023 | 359 | 23,028 (0%) | 0% | 177.2 | 63,600 | Common Stock |
| Oncology Institute Inc | Mihir Shah | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2022 | 94,418 | 94,418 | - | - | Non-Qualified Stock Option (right to buy) | |
| Oncology Institute Inc | Mihir Shah | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2022 | 18,602 | 50,723 | - | 0 | Common Stock | |
| Jones Lang Lasalle Inc | Mihir Shah | Co-CEO JLL Technologies | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Oct 2022 | 5,928 | 25,418 (0%) | 0% | 0 | Common Stock | |
| Jones Lang Lasalle Inc | Mihir Shah | Co-CEO JLL Technologies | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Oct 2022 | 5,928 | 0 | - | - | Restricted Stock Units | |
| Jones Lang Lasalle Inc | Mihir Shah | Co-CEO JLL Technologies | Payment of exercise price or tax liability using portion of securities received from the company at price $ 161.15 per share. | 14 Oct 2022 | 2,940 | 22,478 (0%) | 0% | 161.2 | 473,781 | Common Stock |
| Oncology Institute Inc | Mihir Shah | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2022 | 163,039 | 163,039 | - | - | Stock Options (right to buy) | |
| Oncology Institute Inc | Mihir Shah | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2022 | 32,121 | 32,121 | - | 0 | Class A Common Stock | |
| Jones Lang Lasalle Inc | Mihir Shah | Co-CEO JLL Technologies | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Apr 2022 | 4,136 | 4,136 | - | - | Restricted Stock Units | |
| Jones Lang Lasalle Inc | Mihir Shah | Co-CEO JLL Technologies | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2022 | 14,291 | 26,576 (0%) | 0% | 0 | Common Stock | |
| Jones Lang Lasalle Inc | Mihir Shah | Co-CEO JLL Technologies | Payment of exercise price or tax liability using portion of securities received from the company at price $ 218.84 per share. | 11 Mar 2022 | 7,086 | 19,490 (0%) | 0% | 218.8 | 1,550,700 | Common Stock |
| Jones Lang Lasalle Inc | Mihir Shah | Co-CEO JLL Technologies | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2022 | 1,647 | 12,308 (0%) | 0% | 0 | Common Stock | |
| Jones Lang Lasalle Inc | Mihir Shah | Co-CEO JLL Technologies | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2022 | 1,647 | 0 | - | - | Restricted Stock Units | |
| Jones Lang Lasalle Inc | Mihir Shah | Co-CEO JLL Technologies | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2022 | 909 | 909 | - | - | Restricted Stock Units | |
| Jones Lang Lasalle Inc | Mihir Shah | Co-CEO JLL Technologies | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2022 | 909 | 12,600 (0%) | 0% | 0 | Common Stock | |
| Jones Lang Lasalle Inc | Mihir Shah | Co-CEO JLL Technologies | Payment of exercise price or tax liability using portion of securities received from the company at price $ 254.68 per share. | 15 Jan 2022 | 617 | 11,691 (0%) | 0% | 254.7 | 157,138 | Common Stock |
| Jones Lang Lasalle Inc | Mihir Shah | Co-CEO JLL Technologies | Payment of exercise price or tax liability using portion of securities received from the company at price $ 254.68 per share. | 15 Jan 2022 | 315 | 12,285 (0%) | 0% | 254.7 | 80,224 | Common Stock |
| Jones Lang Lasalle Inc | Mihir Shah | Co-CEO JLL Technologies | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2021 | 25,467 | 25,467 | - | - | Performance Share Units | |
| Jones Lang Lasalle Inc | Mihir Shah | Co-CEO JLL Technologies | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Oct 2021 | 5,928 | 13,755 (0%) | 0% | 0 | Common Stock | |
| Jones Lang Lasalle Inc | Mihir Shah | Co-CEO JLL Technologies | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Oct 2021 | 5,928 | 5,928 | - | - | Restricted Stock Units | |
| Jones Lang Lasalle Inc | Mihir Shah | Co-CEO JLL Technologies | Payment of exercise price or tax liability using portion of securities received from the company at price $ 256.39 per share. | 14 Oct 2021 | 3,094 | 10,661 (0%) | 0% | 256.4 | 793,271 | Common Stock |
| Jones Lang Lasalle Inc | Mihir Shah | Co-CEO JLL Technologies | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Apr 2021 | 4,634 | 4,634 | - | - | Restricted Stock Units |